Pharmaceutical Warnings: A Changing Landscape
Can brand-name drug companies face failure-to-warn lawsuits from patients who take generic versions of their products? If the innovator stops making the drug, but generics continue to sell, is the brand-name...To view the full article, register now.
Already a subscriber? Click here to view full article